Pitt Panelists Share Insights for Academic Innovators at Startup PGH
The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) teamed with its counterparts... Read more
The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) teamed with its counterparts... Read more
The bathroom is the most dangerous room in a house, and for people with... Read more
REGENTYS™ is a development stage, regenerative medicine company focused on developing treatments for patients with gastrointestinal (GI) disorders. Their first product, ExtraCellular Matrix Hydrogel (ECMH), is a first-in-class, non-pharmacologic, non-surgical treatment option for patients suffering from Ulcerative Colitis.